Results 41 to 50 of about 154,631 (333)

Tumor lysis syndrome with hepatic failure- A rare presentation of undiagnosed metastatic melanoma

JEM Reports, 2023
Background: Tumor Lysis syndrome is an oncologic emergency with high morbidity and mortality. Recognition of the constellation of hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia is critical to identifying the disease in time to intervene.
Nicholas Cochran-Caggiano, Brandon Zaffuto, Ryan Dean   +2 more
doaj   +1 more source

Natural killer cell response to chemotherapy-stressed cancer cells: Role in tumor immunosurveillance. [PDF]

, 2017
Natural killer (NK) cells are innate cytotoxic lymphoid cells that actively prevent neoplastic development, growth, and metastatic dissemination in a process called cancer immunosurveillance.
Borrelli, Cristiana, Cippitelli, Marco, Fionda, Cinzia, Santoni, Angela, Soriani, Alessandra, Zingoni, Alessandra   +5 more
core   +1 more source

Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series

Journal of Family Medicine and Primary Care, 2018
Tumor lysis syndrome is an oncological emergency caused by massive tumor lysis resulting in a constellation of metabolic abnormalities. It is observed most frequently in patients with high-grade hematological malignancies undergoing treatment.
Shehla Basheer Kollathodi, Kavitha Kanjirakadu Parameswaran, Lilly Madhavan, Shalini Kuruvilla   +3 more
doaj   +1 more source

Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma

Autopsy and Case Reports, 2021
Tumor lysis syndrome is a well-characterized and potentially deadly complication of spontaneous or treatment-related tumor destruction, and it is most commonly associated with hematologic malignancies.
Robin Moiseff, Cameron Felty, Xiaoying Liu   +2 more
doaj  

Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient

International Journal of Gerontology, 2014
Tumor lysis syndrome (TLS) is rarely induces after Transarterial chemoembolization for hepatocellular carcinoma. We present a patient with a large hepatocellular carcinoma who received twice transarterial embolization (TAE).
Hsaing-Hung Lin, Wei-Ho Chang, Horng-Yuan Wang, Ming-Jen Chen, Shou-Chuan Shih   +4 more
doaj   +1 more source

Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report

Journal of Medical Case Reports, 2011
Introduction Transient myeloproliferative disorder is a hematologic abnormality characterized by an uncontrolled proliferation of myeloblasts in peripheral blood and bone marrow that primarily affects newborns and babies with Down syndrome.
Hatzistilianou Maria, Hatzipantelis Emmanuel, Papageorgiou Theodotis, Pana Zoe, Tragiannidis Athanasios, Athanassiadou Fani   +5 more
doaj   +1 more source

Tumor lysis syndrome developing intraoperatively

Journal of Anaesthesiology Clinical Pharmacology, 2011
Tumor lysis syndrome is a potentially life threatening condition which is most commonly encountered in patients being treated with chemotherapy. We report a case of spontaneous tumor lysis syndrome that developed intraoperatively in a patient with ...
Ankur Verma, Ruchi Mathur, Munish Chauhan, Prashant Ranjan   +3 more
doaj   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Síndrome de lise tumoral: uma revisão abrangente da literatura Acute tumor lysis syndrome: a comprehensive review

Revista Brasileira de Terapia Intensiva, 2008
A síndrome de lise tumoral é caracterizada pela destruição maciça de células malignas e conseqüente liberação do seu conteúdo no espaço extracelular. Embora possa ocorrer de modo espontâneo, a síndrome de lise tumoral aparece em geral, logo após o início
Michael Darmon, Sandra Malak, Isabelle Guichard, Benoit Schlemmer   +3 more
doaj   +1 more source

STAT: Tumor Lysis Syndrome

Clinical Journal of Oncology Nursing, 2020
Tumor lysis syndrome is when large numbers of rapidly dividing cells are killed and release their contents into the bloodstream. .
openaire   +3 more sources